logo

Celltrion Biologics Drug Substance CMO Deal and Capacity Expansion

Awarded · Incheon · Last reported Mar 2026

Source: Chosunbiz

Project
Awarded

Celltrion signed a contract manufacturing (CMO) deal with a global pharmaceutical company to supply biologics drug substance from 2027 to 2029, worth about 294.9 billion won, potentially increasing to 375.4 billion won. The company has a cumulative CMO backlog exceeding 1 trillion won and plans to consider additional domestic and overseas capacity expansions due to expected growth in sales and ris

Status
Closed
Sector
Manufacturing (Industrial)
Location
Incheon, South Korea
Updated
22 Jul 2026
Source
Chosunbiz

ConstructChat

Ask ConstructChat about Celltrion Biologics Drug Substance CMO Deal and Capacity Expansion

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Celltrion Biologics Drug Substance CMO Deal and Capacity Expansion” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Incheon, Incheon, South Korea. Taiyo aggregates data on it from Chosunbiz.

Participants

Not available for this record.

Status

Original status

awarded

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Celltrion signed a contract manufacturing (CMO) deal with a global pharmaceutical company to supply biologics drug substance from 2027 to 2029, worth about 294.9 billion won, potentially increasing to 375.4 billion won. The company has a cumulative CMO backlog exceeding 1 trillion won and plans to consider additional domestic and overseas capacity expansions due to expected growth in sales and rising CDMO demand.

Original sector

Pharmaceutical Manufacturing

Budget

Location

Country

South Korea

State

Incheon

City

Incheon

Source

Source

Chosunbiz

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial)

Article published date

2026-03-19

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project